NCT00312143View on ClinicalTrials.gov

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

PHASE4CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

De Novo Kidney Transplant Recipients

Interventions

DRUG

Enteric-coated Mycophenolate sodium (EC-MPS)

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY